Studies Cast a Starker Light on Depression Drugs

January 20th, 2010 admin

The value of using antidepressants to treat mild to moderate depression came under fire recently after a study in the Journal of the American Medical Association found that the drugs didn’t work much better than a placebo in those with mild to moderate depression. These findings were widely reported because with 164 million prescriptions written and $10 billion in sales in 2008, according to IMS Health , these antidepressants (called SSRIs) were the third most popular class of therapeutics sold in the U.S. Companies are promoting an ever-increasing arsenal of SSRI’s and a whole new class of drugs—the atypical antipsychotics—for treating depression and other mental disorders. But despite their widespread use, the JAMA study adds to an emerging body of research that raises…


Originally posted on HealthBeatBlog

 
  Related Posts
FDA to Review Bone Drugs After Studies Report Hip Breaks
FDA to Review Bone Drugs After Studies Report Hip Breaks
There have long been safety questions — and lawsuits — over whether bone-building drugs like Merck’s Fosamax can actually increase the chance of femur fractures. Today, the FDA said it was going to take another look at the safety issues. In a posting on its Web site, the FDA said a 2008 examination of data from makers of osteoporosis... 
Spending on Drugs for Kids Rose 10.8% Last Year: Medco Report
Spending on Drugs for Kids Rose 10.8% Last Year: Medco Report
Higher spending on flu drugs related to H1N1 built on a base of increasing use of prescription drugs in children due to obesity, diabetes and other health issues.  Read More →
Illicit Drugs on Campus Are Increasingly the Rx Variety
Here’s something that frankly, disturbed me. My daughter, who just finished her freshman year in college, recently told me, “I can’t believe how many kids at school take prescription drugs on a regular basis. They take Adderall to help them study, Ambien to get to sleep and Xanax to calm down.” It surprised me that at 18 she even knew all... 
A.M. Vitals: Pre-ASCO Studies on Drugs, Ovarian Cancer Screening
A.M. Vitals: Pre-ASCO Studies on Drugs, Ovarian Cancer Screening
Also: the U.K.’s NICE in the crosshairs, NIH unveils conflict-of-interest policy for researchers.  Read More →
Medication and Kids: A Growth Industry
Children have become the new growth industry for prescription drug makers. A study released last month by the pharmacy benefit manager Medco found that 26% of kids under 19—almost 30% of those aged 10 to 19—are now taking prescription medications for a chronic condition. Meanwhile, spending on prescription drugs for children increased by almost... 
Medicare to revisit coverage of anemia drugs
The U.S. Centers for Medicare and medicaid services said on Wednesday it is reviewing its coverage of anemia drugs used to treat patients with kidney disease. [Original News Article] Related NewsGuidelines On Anemia Drugs Undermine Doctors’ Ability To Treat Patients, Say DoctorsAnemia warning backs MedicareMedicare to reduce U.S. payments for... 
Studies Keeping Coming on Roche’s Avastin; Latest Is Positive
Studies Keeping Coming on Roche’s Avastin; Latest Is Positive
We recounted earlier this week that Roche’s cancer drug Avastin had missed achieving its main target in a stomach-cancer study. Today the news is flipped as a new study reported Avastin showed positive results in the treatment of advanced ovarian cancer. The latest showed that women who continued using Avastin alone after receiving Avastin... 
Region D Medicare Recovery Audit Contractor Posts New Issues for DRG Validation
HealthDataInsights, Inc. (HDI), the Medicare recovery audit contractor (RAC) for Region D, recently posted new CMS approved audit issues for RAC review pertaining to Part A inpatient claims and DRG validation.  According to the HDI website, the issues include: Breast Procedures Cardiovascular (Other) Nose, Mouth & Throat Disorders Endocrine,... 
Consumer Reports Asks Readers What Worked for Anxiety and Depression
Consumer Reports Asks Readers What Worked for Anxiety and Depression
Rates of reported side effects of the drugs were higher than in industry-funded studies, but the proportion of people reporting sexual side effects declined from previous surveys.  Read More →
Patients Scramble for Relief in Face of Genzyme Drug Shortage
Patients Scramble for Relief in Face of Genzyme Drug Shortage
Patients who relied on Genzyme for drugs to treat two rare enzyme disorders are scrambling for symptom relief in the face of shortages, the New York Times reports . The biotech has been suffering from production problems at its Allston, Mass. plant, which makes the drugs — Gaucher disease treatment Cerezyme and Fabrazyme, for Fabry disease.... 
  Related Tweets from Twitter
hospicedave (David Stone)  : End-Of-Life Savings: The ?Fool?s Gold? Of Reform? ? Health Affairs Blog - http://ow.ly/2iS6p..
Updated : 2010-07-31T20:35:04Z   |  Reply  |  View Tweet
ricell (Richard Ellison)  : RT @Health_Affairs: Blog: Changing The Name ? But Not The Political Game http://bit.ly/9rvGr2..
Updated : 2010-07-31T15:55:10Z   |  Reply  |  View Tweet
bwchealth (Benjamin Chee)  : Implementing Health Reform: Pre-Existing Condition Coverage ... http://bit.ly/c0oyf8..
Updated : 2010-07-31T15:15:22Z   |  Reply  |  View Tweet
Fierce_Moderate (H. Eugene Good)  : RT @DrDavidBallard: Implementing Health Reform: Pre-Existing Condition Coverage (@Health_Affairs Blog) http://bit.ly/9vwSkr #hcr..
Updated : 2010-07-31T14:30:04Z   |  Reply  |  View Tweet
msumia (Md. Suja Uddin Mia)  : Implementing Health Reform: Pre-Existing Condition Coverage ...: Editor's Note: Earlier posts by Timothy Jost prov... http://bit.ly/ciNwb9..
Updated : 2010-07-31T13:53:01Z   |  Reply  |  View Tweet
  Related News from Digg
No comments yet.

Spam Protection by WP-SpamFree

TOP